ACE2 and heart failure: Another study evaluating the effects of ACE inhibitors, ARBs, and mineralocorticoid receptor antagonists (MRAs) in heart failure patients on soluble plasma concentrations of ACE2 found that ACE inhibitor or ARB use was not a strong predictor of elevated circulating ACE2 levels.